Velarion · Company Intelligence
CompBrief
Fiscal year 2024

Gina Chapman — FY2024 total compensation $9,300,120

Gina Chapman is President and Chief Executive Officer of CARGO Therapeutics, Inc. (CRGX). The company reported total compensation of $9,300,120 for fiscal year 2024.

01

Fiscal year 2024 compensation

Salary$630,800
Bonus$150,000
Stock awards$0
Option awards$8,155,520
Non-equity incentive plan$363,800
Pension and non-qualified deferred compensation$0
All other compensation$0
Total$9,300,120

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure CARGO Therapeutics, Inc. filed April 29, 2025, accession 0001193125-25-103786.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2024President and Chief Executive Officer$630,800$150,000$0$8,155,520$363,800$0$0$9,300,120
FY2023President and Chief Executive Officer$542,113$100,000$0$3,904,776$445,500$0$0$4,992,389

Totals as disclosed in each year's own compensation disclosure for CARGO Therapeutics, Inc..

04

The other named executive officers of CARGO Therapeutics, Inc.

Named executive officerRoleFY2024 total
Gina Chapman this pagePresident and Chief Executive Officer$9,300,120
Anup RadhakrishnanChief Financial Officer and Chief Operating Officer$3,975,265
Ginna LaportChief Medical Officer$2,796,680

The company's named executive officers for fiscal year 2024, and what it reported for each. See the full CARGO Therapeutics, Inc. compensation brief.

05

The company page

Gina Chapman's compensation sits inside CARGO Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The CARGO Therapeutics, Inc. (CRGX) compensation brief